Selecting the Optimal Candidate for Adjuvant Radiotherapy After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis

被引:99
作者
Abdollah, Firas [1 ]
Suardi, Nazareno [1 ]
Cozzarini, Cesare [2 ]
Gallina, Andrea [1 ]
Capitanio, Umberto [1 ]
Bianchi, Marco [1 ]
Sun, Maxine [3 ]
Fossati, Nicola [1 ]
Passoni, Niccolo Maria [1 ]
Fiorino, Claudio [2 ]
Di Muzio, Nadia [2 ]
Karakiewicz, Pierre I. [3 ]
Rigatti, Patrizio [1 ]
Montorsi, Francesco [1 ]
Briganti, Alberto [1 ]
机构
[1] Univ Vita Salute San Raffaele, Dept Urol, Milan, Italy
[2] Ist Sci San Raffaele, Dept Radiat Therapy, I-20132 Milan, Italy
[3] Univ Montreal, Ctr Hlth, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada
关键词
Neoplasm recurrence; Prostatic neoplasms/pathology; Prostatic neoplasms/surgery; Prostatic neoplasms/mortality; Radiotherapy; Adjuvant; Risk factors; RANDOMIZED CLINICAL-TRIAL; LYMPH-NODE METASTASES; ANDROGEN DEPRIVATION; LOCAL SURGERY; FOLLOW-UP; RISK; COMBINATION; THERAPY;
D O I
10.1016/j.eururo.2012.10.036
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The role of adjuvant radiotherapy (ART) after radical prostatectomy (RP) on survival of patients with prostate cancer (PCa) is still controversial. Objective: We tested the impact of ART on cancer-specific mortality (CSM) and overall mortality (OM) in PCa patients according to pathologic PCa features. Design, setting, and participants: We evaluated 1049 PCa patients treated with RP and extended pelvic lymph node dissection alone or in combination with adjuvant treatments between 1998 and 2008. All patients had positive surgical margins and/or pT3/pT4 disease with or without positive lymph nodes. Outcome measurements and statistical analysis: Cox regression analyses tested the relationship between pathologic characteristics and CSM rates. Independent predictors of survival were used to develop a novel risk score based on the number of risk factors. Finally, Cox regression models tested the relationship between ART and survival according to the number of risk factors. Results and limitations: On multivariable analyses, only pathologic Gleason score >= 8, pT3b/T4 stage, and presence of positive lymph nodes represented independent predictors of CSM (all p <= 0.02). The cumulative number of these pathologic findings was used to develop a risk score, which was 0, 1, 2, and 3 in 43.6%, 22.1%, 20.7%, and 13.6% of patients, respectively. In patients sharing more than two mentioned predictors of CSM (primarily having a risk score of 0 or 1), ART did not significantly improve survival (all p >= 0.4). Conversely, in patients with a risk score >= 2, ART was associated with lower CSM and OM rates (all p = 0.006). The observational nature of the cohort represents a limitation of the study. Conclusions: ART significantly improved survival only in patients with at least two of the following pathologic features at RP: Gleason score >= 8, pT3/pT4 disease, and positive lymph nodes. These patients represent the ideal candidates for ART after RP. (c) 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:998 / 1008
页数:11
相关论文
共 23 条
  • [1] Decreasing Rate and Extent of Lymph Node Staging in Patients Undergoing Radical Prostatectomy May Undermine the Rate of Diagnosis of Lymph Node Metastases in Prostate Cancer
    Abdollah, Firas
    Sun, Maxine
    Thuret, Rodolphe
    Budaeus, Lars
    Jeldres, Claudio
    Graefen, Markus
    Briganti, Alberto
    Perrotte, Paul
    Rigatti, Patrizio
    Montorsi, Francesco
    Karakiewicz, Pierre I.
    [J]. EUROPEAN UROLOGY, 2010, 58 (06) : 882 - 892
  • [2] Postoperative radiotherapy after radical prostatectomy:: a randomised controlled trial (EORTC trial 22911)
    Bolla, M
    van Poppel, H
    Collette, L
    van Cangh, P
    Vekemans, K
    Da Pozzo, L
    de Reijke, TM
    Verbaeys, A
    Bosset, JF
    van Velthoven, R
    Maréchal, JM
    Scalliet, P
    Haustermans, K
    Piérart, M
    [J]. LANCET, 2005, 366 (9485) : 572 - 578
  • [3] Early Salvage Radiation Therapy Does Not Compromise Cancer Control in Patients with pT3N0 Prostate Cancer After Radical Prostatectomy: Results of a Match-controlled Multi-institutional Analysis
    Briganti, Alberto
    Wiegel, Thomas
    Joniau, Steven
    Cozzarini, Cesare
    Bianchi, Marco
    Sun, Maxine
    Tombal, Bertrand
    Haustermans, Karin
    Budiharto, Tom
    Hinkelbein, Wolfgang
    Di Muzio, Nadia
    Karakiewicz, Pierre I.
    Montorsi, Francesco
    Van Poppel, Hein
    [J]. EUROPEAN UROLOGY, 2012, 62 (03) : 472 - 487
  • [4] Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2-4 pN+ Prostate Cancer: Results of a Matched Analysis
    Briganti, Alberto
    Karnes, R. Jeffrey
    Da Pozzo, Luigi Filippo
    Cozzarini, Cesare
    Capitanio, Umberto
    Gallina, Andrea
    Suardi, Nazareno
    Bianchi, Marco
    Tutolo, Manuela
    Salonia, Andrea
    Di Muzio, Nadia
    Rigatti, Patrizio
    Montorsi, Francesco
    Blute, Michael
    [J]. EUROPEAN UROLOGY, 2011, 59 (05) : 832 - 840
  • [5] Two Positive Nodes Represent a Significant Cut-off Value for Cancer Specific Survival in Patients with Node Positive Prostate Cancer. A New Proposal Based on a Two-Institution Experience on 703 Consecutive N plus Patients Treated with Radical Prostatectomy, Extended Pelvic Lymph Node Dissection and Adjuvant Therapy
    Briganti, Alberto
    Karnes, Jeffrey R.
    Da Pozzo, Luigi Filippo
    Cozzarini, Cesare
    Gallina, Andrea
    Suardi, Nazareno
    Bianchi, Marco
    Freschi, Massimo
    Doglioni, Claudio
    Fazio, Ferruccio
    Rigatti, Patrizio
    Montorsi, Francesco
    Blute, Michael L.
    [J]. EUROPEAN UROLOGY, 2009, 55 (02) : 261 - 270
  • [6] Biochemical Recurrence After Radical Prostatectomy: Multiplicative Interaction Between Surgical Margin Status and Pathological Stage
    Budaeus, Lars
    Isbarn, Hendrik
    Eichelberg, Christian
    Lughezzani, Giovanni
    Sun, Maxine
    Perrotte, Paul
    Chun, Felix K. H.
    Salomon, Georg
    Steuber, Thomas
    Koellermann, Jens
    Sauter, Guido
    Ahyai, Sascha A.
    Zacharias, Mario
    Fisch, Margit
    Schlomm, Thorsten
    Haese, Alexander
    Heinzer, Hans
    Huland, Hartwig
    Montorsi, Francesco
    Graefen, Markus
    Karakiewicz, Pierre I.
    [J]. JOURNAL OF UROLOGY, 2010, 184 (04) : 1341 - 1346
  • [7] International Variation in Prostate Cancer Incidence and Mortality Rates
    Center, Melissa M.
    Jemal, Ahmedin
    Lortet-Tieulent, Joannie
    Ward, Elizabeth
    Ferlay, Jacques
    Brawley, Otis
    Bray, Freddie
    [J]. EUROPEAN UROLOGY, 2012, 61 (06) : 1079 - 1092
  • [8] NEED FOR HIGH RADIATION DOSE (≥70 GY) IN EARLY POSTOPERATIVE IRRADIATION AFTER RADICAL PROSTATECTOMY: A SINGLE-INSTITUTION ANALYSIS OF 334 HIGH-RISK, NODE-NEGATIVE PATIENTS
    Cozzarini, Cesare
    Montorsi, Francesco
    Fiorino, Claudio
    Alongi, Filippo
    Bolognesi, Angelo
    Da Pozzo, Luigi Filippo
    Guazzoni, Giorgio
    Freschi, Massimo
    Roscigno, Marco
    Scattoni, Vincenzo
    Rigatti, Patrizio
    Di Muzio, Nadia
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (04): : 966 - 974
  • [9] EVALUATING THE YIELD OF MEDICAL TESTS
    HARRELL, FE
    CALIFF, RM
    PRYOR, DB
    LEE, KL
    ROSATI, RA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (18): : 2543 - 2546
  • [10] Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO